Position in BBIO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$282,130
-$136,919 QoQ
Shares Held
3,788
-32.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#322
of 469 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in BBIO Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Inspire Advisors, LLC holds $5,818,365 across 11 Biotechnology names. BBIO ranks #6 (4.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INCY |
Incyte Corp
|
16,711 | $1,894,358 | |
| 2 | CRSP |
CRISPR Therapeutics AG
|
19,880 | $1,084,255 | |
| 3 | EXEL |
Exelixis, Inc.
|
16,370 | $890,691 | |
| 4 | TGTX |
Tg Therapeutics, Inc.
|
8,271 | $454,408 | |
| 5 | KRYS |
Krystal Biotech, Inc.
|
958 | $356,059 | |
| 6 | BBIO |
BridgeBio Pharma, Inc.
This page
|
3,788 | $282,130 | |
| 7 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
3,408 | $277,786 | |
| 8 | STOK |
Stoke Therapeutics, Inc.
|
8,423 | $275,600 |
All Filings in BBIO
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $282,130 | 3,788 | Shares | Defined | 2026-08-13 | |
| 2026-03-31 | $419,049 | 5,643 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $482,498 | 6,308 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $651,431 | 12,542 | Shares | Sole | 2025-10-29 | |
| No filing history on record for this holder in this stock. | ||||||